Trackmaster

About Trackmaster

Trackmaster, the next-generation Everolimus-Eluting Coronary Stent System, is designed for exceptional flexibility, controlled drug release, and superior clinical outcomes. Engineered with ultra-thin strut technology, Trackmaster ensures seamless vessel adaptability, reduced arterial injury, and optimized endothelialization.

Manufactured at Kamal Medtech's state-of-the-art 50,000 sq. ft. facility, Trackmaster meets global healthcare standards, offering unmatched safety and effectiveness for complex coronary interventions.

Key Features

01 - Optimized Drug Release Profile

Controlled Everolimus release up to 50 days, ensuring gradual healing and minimal restenosis risk.

02 - Bioresorvable Polymer Coating

Fully degrades through hydrolysis and enzymatic degradation, naturally excreting from the body as CO₂ and H₂O.

03 - Ultra-Thin Strut Design (65µm)

Enhances stent flexibility, reducing vessel trauma and improving crossability in complex anatomies.

04 - Exceptional Radial Strength & Precision Placement

Ensures uniform vessel support, maintaining integrity without foreshortening or recoil.

05 - Engineered for Complex Lesions

Designed for superior deliverability in tortuous vessels, offering seamless tracking and expansion.

Technical Components

Polymers

Biodegradable polymers blend, act as a binding factor for the drug. The unique and validated formulation help drug release in a controlled fashion.

PTCA Balloon Catheter

Drug coated stent is mounted on the balloon portion of PTCA balloon Catheter, the latter assists in stent positioning & dilatation. The Ultra-low profile, excellent crossability and flexible tip of PTCA balloon Catheter help entire stent system to achieve its expected clinical outcomes.

Cobalt Chromium Stent Platform

Meticulously laser cut Cobalt Chromium Stent proves to be an ideal platform for DES, contributing to high flexibility, conformability, unidirectional expansion with no edge flaring and minimum recoil.

Everolimus Drug

The cytostatic drug, inhibits blood vessel restenosis by limiting the proliferation of smooth muscle cells